A Clinical Trial to Evaluate the Effects of a Supplement on Symptoms Associated With Liver and Digestive Health

Part of paid clinical trials in Las Vegas, Nevada.

Sponsor
Edenboost
Study ID
NCT07738744
Status
Completed

Conditions

  • Abdominal Bloating
  • Abdominal Pain
  • Digestive Health
  • Energy Levels
  • Fatigue
  • Liver Health
  • Nausea

Eligibility Criteria

Sex
ALL
Age
40 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Edenboost Alpha Cleanse — DIETARY_SUPPLEMENT
    All participants receive Edenboost Alpha Cleanse (two capsules once daily with the first meal of the day) for 12 weeks.

Study Details

This study will evaluate the effects of Edenboost Alpha Cleanse, a dietary supplement, on symptoms associated with liver and digestive health. The study is a single-arm, open-label trial in which all 40 enrolled participants will use the test product daily for 12 weeks. Participants will complete questionnaires at Baseline, Week 4, Week 8, and Week 12, and will undergo blood testing (hepatic function panel) at Baseline and Week 12. Primary outcomes focus on changes in liver function biomarkers, while secondary outcomes capture participants' self-reported experiences of energy levels, abdominal bloating, abdominal pain, fatigue, and nausea.

Key Dates

First listed
Jul 31, 2026
Start date
Nov 17, 2025
Status verified
Jul 2026
Primary completion
Jan 15, 2026
Completion
Jan 15, 2026

Study Design

Enrollment
40 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Edenboost Alpha Cleanse

Primary Outcome Measure

Change in Alanine Aminotransferase (ALT/SGPT) [ Time Frame: Baseline and Week 12 ]

Locations (1)

FacilityCityStateZIPSite coordinators
CitruslabsLas VegasNevada89118-

Find similar trials in Las Vegas, NV

By research site
Citruslabs· Las Vegas, NV

Related Studies